✦ LIBER ✦

Antisense oligonucleotides as personalized medicine for Duchenne muscular dystrophy

✍ Scribed by van Deutekom, Judith C.; de Kimpe, Sjef J.; Campion, Giles V.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical Trials Using Antisense Oligonuc

✍ Koo, Taeyoung; Wood, Matthew J. 📂 Article 📅 2013 🏛 Mary Ann Liebert 🌐 English ⚖ 220 KB

P.11.17 Optimization of preclinical anti

✍ Kolfschoten, I.G.M.; Janson, A.A.M.; den Eijnde, R.E.Y.van; Bijl, S.; Zonneveld- 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 61 KB

Technology Insight: therapy for Duchenne

✍ Lim, Leland E; Rando, Thomas A 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 456 KB

T.P.1 05 Antisense oligonucleotide desig

✍ A. Aartsma-Rus; C.L. de Winter; W.E. Kaman; A.A.M. Janson; J.C.T. van Deutekom 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 43 KB

Antisense oligonucleotides in the treatm

✍ Steve D. Wilton; Susan Fletcher 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 72 KB

Challenges to oligonucleotides-based the

✍ Aurélie Goyenvalle; Kay E Davies 📂 Article 📅 2011 🏛 BioMed Central 🌐 English ⚖ 230 KB